ABC.L Regulatory News (ABC)

6 Dec 2007 09:29

ABCAM Plc06 December 2007 For immediate release 6 December 2007 ABCAM PLC ("Abcam" or "the Company") Director's Dealings Cambridge UK, 6 December 2007: Abcam plc announces that, on 5 December 2007,Professor Tony Kouzarides, a Non-Executive Director, sold 160,000 OrdinaryShares of 1p each in the Company at a price of 325p per share. Following thedisposal Prof Kouzarides has a beneficial interest in 199,080 shares,representing 0.57% of the Company's issued share capital. For further information please contact: Abcam + 44 (0) 1223 696000 Jonathan Milner, Chief Executive OfficerJeffrey Iliffe, Chief Financial Officerwww.abcam.com Numis Securities + 44 (0) 20 7776 1500James BlackBuchanan Communications + 44 (0) 20 7466 5000Mark Court / Mary-Jane Johnson Notes for editors: About Abcam plc Abcam is a producer and distributor of research-grade antibodies headquarteredin Cambridge, UK, with a US office located in Cambridge, Massachusetts and aJapanese office in Tokyo. Abcam was admitted to AIM in November 2005 and tradesunder the ticker symbol ABC. The Company produces and distributes its own andthird party produced antibodies to academic and commercial users throughout theworld with product information provided and ordering available through theCompany's website, www.abcam.com. The antibodies are sold under the Abcam brandname. The Company's vision is to build the largest online antibody resource inthe world while also ensuring that the antibodies are of high quality andcommercially viable. Abcam now has an online catalogue of approximately 40,000products, most of which are antibodies, from over 200 suppliers supported byup-to-date and detailed technical data sheets, which are created by the Company.The Company currently employs 140 staff in its three operating companies. This information is provided by RNS The company news service from the London Stock Exchange